OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market, and Pink® Open Market.
Our OTC Link Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN, OTC Link NQB, and MOON ATS are each an SEC-regulated ATS, operated by OTC Link LLC, a FINRA and SEC-registered broker-dealer, member SIPC.
Key Facts
Number of securities: +12,000, including international securities, banks, billion+ companies and SEC reporting companies
Industries include: financial services, metals & mining, oil & gas, pharmaceuticals & biotechnology, healthcare, telecommunications, technology, retail, media, utilities, and many more
Total annual dollar volume: $478 billion* up 24.8% vs. 2023
90+ broker-dealer subscribers to our OTC Link® ATS
OTC Markets Group Market Data is distributed by most major financial data distributors, including Bloomberg, Refinitiv, ICE Data Services, Factset, Fidessa, NASDAQ and SIX Financial. View the market data distributors and financial portals that display our data.
OTC Markets Group is publicly-traded on the OTCQX market under the symbol OTCM
*As of December 31, 2024
Learn more about OTC Markets Group, our history, our management team and our operations
Proper naming convention for OTCQX, OTCQB and Pink trading symbols
For press-related inquiries, please contact:
OTC Markets Group Inc.
+1 212-896-4428